Effect Modification of Selenium Supplementation by Intake and Serum Concentrations of Antioxidants on the Development of Metachronous Colorectal Adenoma

Overview

Journal Nutr Cancer

Publisher Routledge

Specialties Nutritional Sciences
Oncology

Date 2022 Oct 22

PMID 36272100

Authors

Elizabeth T Jacobs

Jessica Martinez

Ken Batai

Peter Lance

Mario Trejo

Kathylynn Saboda

Catherine Cordova

Wade Chew

Magdiel Habila

H-H Sherry Chow

Affiliations

Soon will be listed here.

Abstract

Background: Selenium (Se) is a trace element that has been investigated as a potential chemopreventive agent for colorectal cancer. Dietary intake of other antioxidant nutrients may modify the effect of Se.

Objective: We examined the association between intake and serum concentrations of retinol, β-carotene, β-cryptoxanthin, lycopene, lutein/zeaxanthin, and α- and γ-tocopherol and the development of metachronous colorectal adenoma, and if these nutrients modified the effect of Se.

Methods: We conducted a prospective study of 1874 participants from the Se Trial with data for antioxidant intake, as well as a subcohort of 508 participants with serum biomarker concentrations.

Results: Statistically significantly lower odds for the development of metachronous adenoma were observed for those participants in the highest tertile of intake for lutein/zeaxanthin compared to the lowest, with an OR (95% CI) of 0.72 (0.56-0.94). No effect modification for intake of any nutrient was observed. However, circulating concentrations of lycopene exhibited statistically significant effect modification of selenium supplementation ( < 0.06).

Conclusion: These findings show that intake and circulating concentrations of antioxidant nutrients were not consistently associated with reduced odds for the development of metachronous lesions, although blood concentrations of lycopene may modify the effect of selenium supplementation.

References

Nkondjock A, Ghadirian P . Dietary carotenoids and risk of colon cancer: case-control study. Int J Cancer. 2004; 110(1):110-6. DOI: 10.1002/ijc.20066. View

Ritenbaugh C, Aickin M, Taren D, Teufel N, Graver E, Woolf K . Use of a food frequency questionnaire to screen for dietary eligibility in a randomized cancer prevention phase III trial. Cancer Epidemiol Biomarkers Prev. 1997; 6(5):347-54. View

Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D . The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004; 164(21):2335-42. DOI: 10.1001/archinte.164.21.2335. View

Greenberg E, Baron J, Stukel T, Stevens M, Mandel J, Spencer S . A clinical trial of beta carotene to prevent basal-cell and squamous-cell cancers of the skin. The Skin Cancer Prevention Study Group. N Engl J Med. 1990; 323(12):789-95. DOI: 10.1056/NEJM199009203231204. View

Thompson P, Ashbeck E, Roe D, Fales L, Buckmeier J, Wang F . Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 2016; 108(12). PMC: 6272807. DOI: 10.1093/jnci/djw152. View

Omenn G, Goodman G, Thornquist M, Balmes J, Cullen M, Glass A . Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996; 334(18):1150-5. DOI: 10.1056/NEJM199605023341802. View

Jiang J, Suzuki S, Xiang J, Kuriki K, Hosono A, Arakawa K . Plasma carotenoid, alpha-tocopherol and retinol concentrations and risk of colorectal adenomas: A case-control study in Japan. Cancer Lett. 2005; 226(2):133-41. DOI: 10.1016/j.canlet.2005.03.040. View

Hennekens C, Buring J, Manson J, Stampfer M, Rosner B, Cook N . Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996; 334(18):1145-9. DOI: 10.1056/NEJM199605023341801. View

Lippman S, Goodman P, Klein E, Parnes H, Thompson Jr I, Kristal A . Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005; 97(2):94-102. DOI: 10.1093/jnci/dji009. View

10.

Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J . Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief. 2011; (61):1-8. View

11.

Terry P, Jain M, Miller A, Howe G, Rohan T . Dietary carotenoid intake and colorectal cancer risk. Nutr Cancer. 2002; 42(2):167-72. DOI: 10.1207/S15327914NC422_3. View

12.

Starczak M, Zarakowska E, Modrzejewska M, Dziaman T, Szpila A, Linowiecka K . In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease. J Transl Med. 2018; 16(1):204. PMC: 6053776. DOI: 10.1186/s12967-018-1581-9. View

13.

Greenberg E, Baron J, Tosteson T, Freeman Jr D, Beck G, Bond J . A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med. 1994; 331(3):141-7. DOI: 10.1056/NEJM199407213310301. View

14.

Erhardt J, Meisner C, Bode J, Bode C . Lycopene, beta-carotene, and colorectal adenomas. Am J Clin Nutr. 2003; 78(6):1219-24. DOI: 10.1093/ajcn/78.6.1219. View

15.

Clark L, Combs Jr G, Turnbull B, Slate E, Chalker D, Chow J . Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996; 276(24):1957-63. View

16.

Ubago-Guisado E, Rodriguez-Barranco M, Ching-Lopez A, Petrova D, Molina-Montes E, Amiano P . Evidence Update on the Relationship between Diet and the Most Common Cancers from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: A Systematic Review. Nutrients. 2021; 13(10). PMC: 8540388. DOI: 10.3390/nu13103582. View

17.

Duffield-Lillico A, Reid M, Turnbull B, Combs Jr G, Slate E, Fischbach L . Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev. 2002; 11(7):630-9. View

18.

Thompson P, Ashbeck E, Roe D, Fales L, Buckmeier J, Wang F . Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst. 2016; 108(12). PMC: 6272806. DOI: 10.1093/jnci/djw151. View

19.

Reid M, Duffield-Lillico A, Sunga A, Fakih M, Alberts D, Marshall J . Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer. 2005; 118(7):1777-81. DOI: 10.1002/ijc.21529. View

20.

Chapelle N, Martel M, Toes-Zoutendijk E, Barkun A, Bardou M . Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population. Gut. 2020; 69(12):2244-2255. PMC: 7677480. DOI: 10.1136/gutjnl-2020-320990. View